Patient safety as part of your clinical development strategy
Early adoption of a robust PV system early in clinical development program is critical. Learn how a robust PV system should be adopted as a part of your strategy to smoothen the functioning of clinical trials.
Download Now
Article Highlights
- Major safety challenges with cellular therapies
- Need for Pharmacovigilance in strategizing the cell and gene therapy safety requirements
- Risk monitoring considerations
- Building a predictive and responsive safety strategy for cell and gene therapy products.